This Publication is No. 11789-IMM from the Department of Immunology, The Scripps Research Institute, 10550 North Torrey Pines Road/IMM3, La Jolla, CA 92037. The work of the author reported herein was supported, in part, by NIH grants AR39555, AR31203, and AG15061.
Buhl AM , Cambier JC . Co-receptor and accessory regulation of B-cell antigen receptor signal transduction . Immunol Rev1997; 160: 127–138 .
2.
Healy JI , Goodnow CC . Positive versus negative signaling by lymphocyte antigen receptors . Annu Rev Immunol1998; 16: 645–670 .
3.
Hibbs ML et al. Multiple defects in the immune system of Lyndeficient mice, culminating in autoimmune disease . Cell1995; 83: 301–311 .
4.
Chan VW et al. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and downregulation . Immunity1997; 7: 69–81 .
5.
Nishizumi H et al. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice . Immunity1995; 3: 549–560 .
6.
O'Keefe TL , Williams GT , Davies SL , Neuberger MS . Hyperresponsive B cells in CD22-deficient mice . Science1996; 274: 798–801 .
7.
Shultz LD et al. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene . Cell1993; 73: 1445–1454 .
8.
Tsui HW , Siminovitch KA , deSouza L , Tsui FWL . Motheaten and viable motheaten mice have mutations in the hematopoeitic cell phosphatase gene . Nat Genet1993; 4: 124–129 .
9.
Nishizumi H , Horikawa K , Mlinaric-Rascan I , Yamamoto T . A double-edged kinase Lyn: a positive and negative regulator for antigen receptor-mediated signals . J Exp Med1998; 187: 1343–1348 .
10.
Cornall RJ et al. Polygenic autoimmune traits: Lyn, CD22 and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection . Immunity1998; 8: 497–508 .
11.
Chan VW , Lowell CA , DeFranco AL . Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes . Curr Biol1998; 8: 545–553 .
12.
Kato J et al. Affinity maturation in Lyn kinase-deficient mice with defective germinal center formation . J Immunol1998; 160: 4788–4795 .
13.
Nitschke L et al. CD22 is a negative regulator of B-cell receptor signalling . Curr Biol1997; 7: 133–143 .
14.
Tedder TF , Tuscano J , Sato S , Kehrl JH . CD22, a B lymphocytespecific adhesion molecule that regulates antigen receptor signaling . Annu Rev Immunol1997; 15: 481–504 .
15.
Yu CC et al. B and T cells are not required for the viable motheaten phenotype . J Exp Med1996; 183: 371–380 .
16.
Smith KGC et al. Inhibition of the B cell by CD22: a requirement for Lyn . J Exp Med1998; 187: 807–811 .
17.
Wang J . Altered antigen receptor signaling and impaired Fasmediated apoptosis of B cells in Lyn-deficient mice . J Exp Med1996; 184: 831–838 .
Tridandapani S et al. Negative signaling in B cells: SHIP Grbs Shc . Immunol Today1997; 18: 424–427 .
20.
Coggeshall KM . Inhibitory signaling by B cell Fc gamma RIIb . Curr Opin Immunol1998; 10: 306–312 .
21.
D'Ambrosio D et al. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc-gamma RIIB1 . Science1995; 268: 293–297 .
22.
Nadler MJS et al. Protein-tyrosine phosphatase SHP-1 is dispensable for Fc gamma RIIB-mediated inhibition of B cell antigen receptor activation . J Biol Chem1997; 272: 20038–20043 .
23.
Tivol EA et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4 . Immunity1995; 3: 541–547 .
24.
Tivol EA , Schweitzer AN , Sharpe AH . Costimulation and autoimmunity . Curr Opin Immunol1996; 8: 822–830 .
25.
Waterhouse P et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4 . Science1995; 270: 985–988 .
26.
Tivol EA et al. CTLA-4 Ig prevents lymphoproliferative and fatal multiorgan tissue destruction in CTLA-4-deficient mice . J Immunol1997; 158: 5091–5094 .
27.
Taylor GA et al. A pathogenetic role for TNFa in the syndrome of cachexia, arthritis and autoimmunity resulting from tristetraprolin (TTP) deficiency . Immunity1996; 4: 445–454 .
28.
Carballo E , Gilkeson GS , Blackshear PJ . Bone marrow transplantation reproduces the tristetraprolin-deficiency syndrome in recombination activating gene-2 (-/-) mice. Evidence that monocyte= macrophage progenitors may be responsible for TNFalpha overproduction . J Clin Invest1997; 100: 986–995 .
29.
Dang H et al. SLE-like autoantibodies and Sjogren's syndrome-like lymphoproliferation in TGF-beta knockout mice . J Immunol1995; 155: 3205–3212 .
30.
Sadlack B et al. Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4/ T cells . Eur J Immunol1995; 25: 3053–3059 .
31.
Willerford DM et al. Interleukin-2 receptor a chain regulates the size and content of the peripheral lymphoid compartment . Immunity1995; 3: 521–530 .
32.
Suzuki H et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor b . Science1995; 268: 1472–1476 .
33.
van Parijs L et al. Functional responses and apoptosis of CD25 (IL-2R alpha)-deficient T cells expressing a transgenic antigen receptor . J Immunol1997; 158: 3738–3745 .
34.
Refaeli Y et al. Biochemical mechanisms of IL-2-regulated Fasmediated T cell apoptosis . Immunity1998; 8: 615–623 .
35.
Adachi M et al. Enhanced and accelerated lymphoproliferation in Fas-null mice . Proc Natl Acad Sci USA1996; 93: 2131–2136 .
36.
Walport MJ , Davies KA , Morley BJ , Botto M . Complement deficiency and autoimmunity . Ann NY Acad Sci1997; 815: 267–281 .
37.
Botto M et al. Homozygous C1q deficiency caused glomerulonephritis associated with multiple apoptotic bodies . Nat Genet1998; 19: 56–59 .
38.
Carroll MC . The lupus paradox . Nat Genet1998; 19: 3–4 .
39.
Carroll MC . The role of complement and complement receptors in induction and regulation of immunity . Annu Rev Immunol1998; 16: 545–568 .
40.
Cutler AJ et al. T cell-dependent immune response in C1q-deficient mice: defective interferon gamma production by antigen-specific T cells . J Exp Med1998; 187: 1789–1797 .
41.
Hammerberg C , Katiyar SK , Carroll MC , Cooper KD . Activated complement component 3 (C3) is required for ultraviolet induction of immunosuppression and antigenic tolerance . J Exp Med1998; 187: 1133–1138 .
42.
Strasser A et al. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease . Proc Natl Acad Sci USA1991; 88: 8661–8665 .
43.
McDonnell TJ et al. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation . Cell1989; 57: 79–88 .
44.
Katsumata M et al. Differential effects of Bcl-2 on T and B cells in transgenic mice . Proc Natl Acad Sci USA1998; 89: 11376–11380 .
45.
Lopez-Hoyos M et al. Constitutive expression of bcl-2 in B cells causes a lethal form of lupus-like autoimmune disease after induction of neonatal tolerance to H-2b alloantigens . J Exp Med1996; 183: 2523–2531 .
46.
Nisitani S et al. The bcl-2 gene product inhibits clonal deletion of self-reactive B lymphocytes in the periphery but not in the bone marrow . J Exp Med1993; 178: 1247–1254 .
47.
Hartley SB et al. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death . Cell1993; 72: 325–335 .
48.
Lang J et al. Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen-dependent manner and promotes receptor editing in autoreactive, immature B cells . J Exp Med1997; 186: 1513–1522 .
49.
Hande S , Notidis E , Manser T . Bcl-2 obstructs negative selection of autoreactive, hypermutated antibody V regions during memory B cell development . Immunity1998; 8: 189–198 .
50.
O'Garra A . Cytokines induce the development of functionally heterogeneous T helper cell subsets . Immunity1998; 8: 275–283 .
51.
Seery JP , Carroll JM , Cattell V , Watt FM . Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis . J Exp Med1997; 186: 1451–1459 .
52.
Erb KJ et al. Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice . J Exp Med1997; 852: 329–339 .
53.
Muller W , Kuhn R , Rajewsky K . Major histocompatibility complex class II hyperexpression on B cells in interleukin 4-transgenic mice does not lead to B cell proliferation and hypergammaglobulinemia . Eur J Immunol1991; 21: 921–925 .
54.
Lewis DB et al. Interleukin 4 expressed in situ selective alters thymocyte development . J Exp Med1991; 173: 89–100 .
55.
Theofilopoulos AN , Kono DH . Murine lupus models: gene-specific and genome-wide studies. In: Lahita RG (ed.) Systemc Lupus Erythematosus3rd edition. Academic Press: San Diego , 1998 (in press).
56.
Tedder TF , Inaoki M , Sato S . The CD19–CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity . Immunity1997; 6: 107–118 .
57.
Sato S et al. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity . J Immunol1996; 157: 4371–4378 .
58.
Inaoki M et al. CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes . J Exp Med1997; 186: 1923–1931 .
59.
Zhang L et al. An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes . Mol Cell Biol1995; 15: 6961–6970 .
60.
Bullard DC et al. Intercellular adhesion molecule-1 deficiency protects MRL/MpJ-Fas (lpr) mice from early lethality . J Immunol1997; 159: 2058–2067 .
61.
Lloyd CM . Intercellular adhesion molecule-1 deficiency protects MRL/MpJ-Fas (lpr) mice from early lethality . J Clin Invest1997; 100: 963–967 .
62.
Gilkeson GS et al. Clinical and serologic manifestations of autoimmune disease in MRL-lpr/lpr mice lacking nitric oxide synthase type 2 . J Exp Med1997; 186: 365–373 .
63.
Weinberg JB et al. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine . J Exp Med1994; 179: 651–660 .
64.
Oates JC et al. Effect of late modulation of nitric oxide production on murine lupus . Clin Immunol Immunopathol1997; 83: 86–92 .
65.
Jevnikar AN , Grusby MJ , Glimcher LH . Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice . J Exp Med1994; 179: 1137–1143 .
66.
Koh DR et al. Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells . Eur J Immunol1995; 25: 2558–2562 .
67.
Maldonado MA et al. Greatly reduced lymphoproliferation in lpr mice lacking major histocompatibility complex class I . J Exp Med1995; 181: 641–649 .
68.
Giese T , Davidson WF . In CD8/ T cell deficient lpr/lpr mice, CD4+B220+ and CD4+B220- T cells replace B220/ doublenegative T cells as the predominant population in enlarged lymph nodes . J Immunol1995; 154: 4986–4995 .
69.
Ohteki T , Iwamoto M , Izui S , MacDonald HR . Reduced development of CD4ÿ8ÿB220/ T cells but normal autoantibody production in lpr/lpr mice lacking major histocompatibility complex class I molecules . Eur J Immunol1995; 25: 37–41 .
70.
Christianson GJ et al. b2-Microglobulin dependence of the lupus-like autoimmune syndrome of MRL-lpr mice . J Immunol1996; 156: 4932–4939 .
71.
Herron LR et al. Selection of the T cell receptor repertoire in lpr mice . J Immunol1993; 151: 3450–3459 .
72.
Giese T , Davidson WF . Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double-negative T cells but not autoantibody production . J Immunol1994; 152: 2000–2010 .
73.
Peng SL et al. Alpha beta T cell regulation and CD40 ligand dependence in murine systemic autoimmunity . J Immunol1997158: 2464–2470 .
74.
Finck BK , Linsley PS , Wofsy D . Treatment of murine lupus with CTLA-4Ig . Science1994; 265: 1225–1227 .
75.
Chu EB et al. Intervention of CD4/ cell subset shifts and autoimmunity in the BXSB mouse by murine CTLA-4Ig . J Immunol1996; 156: 1262–1268 .
76.
Nakajima A et al. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule . Eur J Immunol1995; 25: 3060–3069 .
77.
Mohan C , Shi Y , Laman JD , Datta SK . Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis . J Immunol1995; 154: 1470–1480 .
78.
Daikh DI et al. Long-term inhibition of murine lupus by brief simultaneous blockade of the B7=CD28 and CD40=gp39 costimulation pathways . J Immunol1997; 159: 3104–3108 .
79.
Peng SL et al. Murine lupus in the absence of ab T cells . J Immunol1996; 156: 4041–4049 .
80.
Peng SL , Madaio MP , Hayday AC , Craft J . Propagation and regulation of systemic autoimmunity by gamma delta T cells . J Immunol1996; 157: 5689–5698 .
81.
Peng SL , Craft J . T cells in murine lupus: propagation and regulation of disease . Mol Biol Rep1996; 23: 247–251 .
82.
Peng SLMoslehi J , Robert ME , Craft J . Perforin protects against autoimmunity in lupus-prone mice . J Immunol1998; 160: 652–660 .
83.
Shlomchik MJ et al. The role of B cells in lpr/lpr-induced autoimmunity . J Exp Med1994; 180: 1295–1306 .
84.
Balomenos D , Rumold R , Theofilopoulos AN . The proliferative in vivo activities of lpr double-negative T cells and the primary role of p59fyn in their activation and expansion . J Immunol1997; 159: 2265–2273 .
85.
Sabzevari H , Propp S , Kono DH , Theofilopoulos AN . G1 arrest and high expression of cyclin kinase and apoptosis inhibitors in accumulated activated/memory phenotype CD4/ cells of older lupus mice . Eur J Immunol1997; 27: 1901–1910 .
86.
Peng SL , Moslehi J , Craft J . Roles of interferon-gamma and interleukin-4 in murine lupus . J Clin Invest1997; 99: 1936–1946 .
87.
Balomenos D , Rumold R , Theofilopoulos AN . Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice . J Clin Invest1998; 101: 364–371 .
88.
Haas C , Ryffel B , LeHir M . IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/lpr mice . J Immunol1997; 158: 5485–5491 .
89.
Schwarting A et al. IFN-g receptor signaling is essential for the initiation, acceleration and destruction of autoimmune kidney disease in MRL-Faslpr mice . J Immunol1998; 161: 494–503 .
90.
Haas C , Ryffel B , LeHir M . IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB 6 NZW)F1 mice . J Immunol1998; 160: 3713–3718 .
91.
Clynes R , Dumitru C , Ravetch JV . Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis . Science1998; 279: 1052–1054 .
92.
Santiago M-L et al. Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome . J Exp Med1997; 185: 65–70 .
93.
Ibnou-Zekri N et al. Role of the major histocompatibility complex class II Ea gene in lupus susceptibility in mice . Proc Natl Acad Sci USA1997; 94: 14654–14659 .
94.
Iwamoto M , Ibnou-Zekri N , Kobayakawa T , Izui S . Effect of genetic background on Ead transgene-mediated protection from murine lupus . J Autoimmunol1998; 11: 241–248 .
95.
Nagata S . Apoptosis by death factor . Cell1997; 88: 355–365 .
96.
Kotzin BL , Babcock SK , Herron LR . Deletion of potentially selfreactive T cell receptor specificities in L3T4, Lyt-2 cells of lpr mice . J Exp Med1988; 168: 2221–2229 .
97.
Singer PA et al. Tolerance-related Vb clonal deletions in normal CD4ÿ8ÿ, TCR-a/b/ and abnormal lpr and gld cell populations . J Exp Med1989; 170: 1869–1877 .
98.
Sidman CL , Marshall JD , VonBoehmer H . Transgenic T cell receptor interactions in the lymphoproliferative and autoimmune syndromes of lpr and gld mutant mice . Eur J Immunol1992; 22: 499–504 .
99.
Singer GG , Abbas AK . The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice . Immunity1994; 1: 365–371 .
100.
Sytwu H-K , Liblau RS , McDevitt HO . The roles of Fas/APO-1 (CD95) ad TNF in antigen-induced programmed cell death in T cell receptor transgenic mice . Immunity1996; 5: 17–30 .
101.
Russell JH , Rush B , Weaver C , Wang RD . Mature T-cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide . Proc Natl Acad Sci USA1993; 90: 4409–4413 .
102.
Mogil RJ et al. Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo . Int Immunol1995; 7: 1451–1458 .
103.
Rathmell JC et al. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4/ T cells . Nature1995; 376: 181–184 .
104.
Rathmell JC et al. Expansion or elimination of B cells in vivo: dual roles for CD40-and Fas (CD95)-ligands modulated by the B cell antigen receptor . Cell1996; 87: 319–329 .
105.
Roark JH et al. Breakdown of B cell tolerance in a mouse model of systemic lupus erythematosus . J Exp Med1995; 181: 1157–1167 .
106.
Kench JA , Russell DM , Nemazee DEfficient peripheral clonal elimination of B lymphocytes in MRL/lpr mice bearing autoantibody transgenes . J Exp Med1998; 188: 909–917 .
107.
Drake CG , Babcock SK , Palmer E , Kotzin BL . Genetic analysis of the NZB contribution to lupus-like autoimmune disease . Proc Natl Acad Sci USA1994; 91: 4062–4066 .
108.
Morel L et al. Polygenic control of susceptibility to murine systemic lupus erythematosus . Immunity1994; 1: 219–229 .
109.
Kono DH et al. Lupus susceptibility loci in New Zealand mice . Proc Natl Acad Sci USA1994; 91: 10168–10172 .
110.
Drake CG et al. Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner . J Immunol1995; 154: 2441–2445 .
111.
Vyse TJ et al. Backcross analysis of genes linked to autoantibody production in New Zealand white mice . J Immunol1996; 157: 2719–2722 .
112.
Rozzo SJ , Vyse TJ , Drake CG , Kotzin BL . Effect of genetic background on the contribution of New Zealand black loci to autoimmune lupus nephritis . Proc Natl Acad Sci USA1996; 93: 15164–15169 .
113.
Vyse TJ et al. Control of multiple autoantibodies linked with a lupus nephritis susceptibility locus in New Zealand Black mice . J Immunol1997; 158: 5566–5570 .
114.
Mohan C , Morel L , Yang P , Wakeland EK . Genetic dissection of systemic lupus erythematosus pathogenesis: Sle2 on murine chromosome 4 leads to B cell hyperactivity . J Immunol1997; 159: 454–460 .
115.
Mohan C et al. Genetic dissection of SLE pathogenesis . J Clin Invest1998; 101: 1362–1372 .
116.
Watson ML et al. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal diseasemodifying loci . J Exp Med1992; 176: 1645–1656 .
117.
Wang Y et al. Host modifier genes affect mouse autoimmunity induced by the lpr gene . Am J Pathol1997; 151: 1791–1794 .
118.
Vidal S , Kono DH , Theofilopoulos AN . Loci predisposing to autoimmunity in MRL-Faslpr and C57BL=6-Faslpr mice . J Clin Invest1998; 101: 696–702 .
119.
Hirose S , Tsurui H , Nishimura H , Jiang Y , Shirai T . Mapping of a gene for hypergammaglobulinemia to the distal region on chromosome 4 in NZB mice and its contribution to systemic lupus erythematosus in (NZB 6 NZW) F1 mice . Int Immunol1994; 6: 1857–1864 .
